AJP - GI Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (June 5, 2002). doi:10.1152/ajpgi.00143.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/4/G909    most recent
00143.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.

Articles in PresS, published online ahead of print June 5, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00143.2002
Submitted on April 12, 2002
Accepted on May 31, 2002

PKC-{zeta} Isoform Prevents Oxidant-Induced iNOS Upregulation: Key Mechanism for EGF Protection of Microtubules Cytoskeleton and Intestinal Barrier Integrity

Ali Banan1*, Lei Zhang1, Jeremy Z Fields1, Ashkan Farhadi1, David A Talmage2, and Ali Keshavarzian1

1 Department of Internal Medicine (Section of Gastroenterology and Nutrition), Pharmacology and Molecular Physiology, Rush University College of Medicine, Chicago, IL, USA
2 Institute of Human Nutrition, Columbia University, New York, NY, USA

* To whom correspondence should be addressed. E-mail: ali_banan{at}rush.edu.

Using monolayers of intestinal (Caco-2) cells, we reported that upregulation of iNOS and overproduction of reactive nitrogen metabolites are key to oxidant-induced loss of barrier integrity and that EGF protects against this injury by preventing the oxidation of the microtubule cytoskeleton. Expression of the PKC-zeta ({zeta}) isoform was required for protection. For the current investigation, we hypothesized that PKC-{zeta} activation and iNOS down-regulation are key in EGF protection against oxidative injury. Methods: Wild type (WT) Caco-2 cells were incubated with H2O2 (0.5 mM) ± EGF or PKC modulators. Other WT Caco-2 cells were transfected to stably over-express PKC-{zeta} or to inhibit its expression and then pretreated with EGF or a PKC activator (OAG) prior to oxidant. Results: {A} Relative to WT monolayers exposed to oxidant alone, pretreatment with EGF protected monolayers by 1) increasing PKC-{zeta} activity; 2) decreasing six iNOS related variables [iNOS activity & protein levels, NO levels, oxidative stress, tubulin oxidation & nitration]; 3) increasing stable polymerized tubulin; 4) maintaining the cytoarchitectural integrity of microtubules; and 5) enhancing barrier integrity. {B} Relative to WT cells exposed to oxidant, monolayers of transfected cells stably over-expressing PKC-{zeta} (+2.9 fold) were protected as indicated by decreases in all measures of iNOS driven pathways as well as enhanced stability of the microtubule cytoarchitecture and of barrier function. Over-expression induced inhibition of iNOS was OAG-independent, although EGF potentiated this protection. {C} Anti-sense inhibition of PKC-{zeta} expression (-95%) prevented all measures of EGF protection against iNOS upregulation. Conclusions: (1) EGF protects against oxidative disruption of the intestinal barrier integrity by stabilizing the cytoskeleton, in large part, through the activation of PKC-{zeta} and down-regulation of iNOS; (2) Activation of PKC-{zeta} is by itself required for cellular protection against oxidative stress of iNOS up-regulation. (3) We have thus discovered novel biologic functions - suppression of the iNOS driven reactions and of cytoskeletal oxidation- among the atypical PKC isoforms. Accordingly, increasing PKC-{zeta} signaling is a potentially novel therapeutic strategy in intestinal disorders such as inflammatory bowel disease (IBD) that are associated with oxidative stress injury.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. A. Swystun, B. Renaux, F. Moreau, S. Wen, M. A. Peplowski, M. D. Hollenberg, and W. K. MacNaughton
Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase C{zeta}
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G60 - G70.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Fu, Z. Wang, W. L. Chen, P. K. Moore, and Y. Z. Zhu
Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1545 - H1552.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Farhadi, A. Keshavarzian, Z. Ranjbaran, J. Z. Fields, and A. Banan
The Role of Protein Kinase C Isoforms in Modulating Injury and Repair of the Intestinal Barrier
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Fleegal, S. Hom, L. K. Borg, and T. P. Davis
Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2012 - H2019.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, C. B. Forsyth, S. Choudhary, and A. Keshavarzian
Critical Role of the Atypical {lambda} Isoform of Protein Kinase C (PKC-{lambda}) in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Function of Intestinal Epithelium
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 458 - 471.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian
Novel effect of NF-{kappa}B activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1139 - C1151.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian
Key role of PLC-{gamma} in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C977 - C993.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Badorff and S. Dimmeler
NO Balance: Regulation of the Cytoskeleton in Congestive Heart Failure by Nitric Oxide
Circulation, March 18, 2003; 107(10): 1348 - 1349.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1979 by the American Physiological Society.